Davide Piraino
Overview
Explore the profile of Davide Piraino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez-Sanchez I, Cerrato E, Bollati M, Espejo-Paeres C, Nombela-Franco L, Alfonso-Rodriguez E, et al.
JACC Cardiovasc Interv
. 2024 Nov;
17(22):2681-2691.
PMID: 39603781
Background: Limited data are available to guide the management of coronary artery aneurysms (CAAs). Objectives: The authors sought to define the clinical characteristics, identify variables that predict outcomes, and provide...
2.
Cortese B, Piraino D, Gentile D, Onea H, Lazar L
Catheter Cardiovasc Interv
. 2022 Oct;
100(7):1220-1228.
PMID: 36273435
Left main (LM) stem has different structural and anatomical characteristics compared to all of the other segments of the coronary tree, thus its management through percutaneous coronary intervention (PCI) is...
3.
Cortese B, di Palma G, Garcia Guimaraes M, Piraino D, Orrego P, Buccheri D, et al.
JACC Cardiovasc Interv
. 2020 Nov;
13(24):2840-2849.
PMID: 33248978
Objectives: This study sought to compare the performance of a novel drug-coated balloon (DCB) (Elutax SV, Aachen Resonance, Germany), with an everolimus-eluting stent (EES) (Abbott Vascular, Santa Clara, California) in...
4.
Elwany M, Zaki A, Latib A, Testa L, Ielasi A, Piraino D, et al.
Egypt Heart J
. 2019 Dec;
71(1):31.
PMID: 31845098
Background: Despite the improvement in techniques and tools, coronary lesions involving a bifurcation are still challenging and the outcome with drug-eluting stents is not always optimal. The role of bioresorbable...
5.
Nunez-Gil I, Cerrato E, Bollati M, Nombela-Franco L, Terol B, Alfonso-Rodriguez E, et al.
Int J Cardiol
. 2019 Aug;
299:49-55.
PMID: 31378382
Background: Coronary Aneurysms are a focal dilatation of an artery segment >1.5-fold the normal size of adjacent segments. Although some series have suggested a prevalence of 0.3-12%, data are lacking....
6.
Geraci G, Buccheri D, Zanoli L, Fatuzzo P, Di Natale K, Zammuto M, et al.
Exp Ther Med
. 2019 Mar;
17(4):3255-3263.
PMID: 30906482
Intrarenal hemodynamic alterations are independent predictors of cardiovascular events in different populations. It has been hypothesized that there is an association between renal hemodynamics and coronary atherosclerotic burden in patients...
7.
Ielasi A, Campo G, Cortese B, Leoncini M, Varricchio A, Brugaletta S, et al.
Cardiovasc Revasc Med
. 2018 Oct;
20(8):700-704.
PMID: 30314835
Background: data from clinical experiences with Absorb bioresorbable scaffold (BRS) in STEMI raised concerns among clinicians about the device safety because a noteworthy scaffold thrombosis (ScT) rate was reported at...
8.
Widder J, Cortese B, Levesque S, Berliner D, Eccleshall S, Graf K, et al.
EuroIntervention
. 2018 Jul;
15(4):e382-e388.
PMID: 29992902
Aims: The aim of this study was to investigate the use of a drug-coated balloon (DCB) in daily clinical practice and provide further evidence on the safety and efficacy of...
9.
Moscarella E, Ielasi A, Varricchio A, De Angelis M, Loi B, Tarantini G, et al.
Int J Cardiol
. 2018 Feb;
258:50-54.
PMID: 29429635
Background: The bioresorbable vascular scaffold (BVS) technology may be an appealing option in ST-segment elevation myocardial infarction (STEMI) patients. However, the available evidence on its use in this challenging subset...
10.
Moscarella E, Tanaka A, Ielasi A, Cortese B, Coscarelli S, De Angelis M, et al.
Catheter Cardiovasc Interv
. 2018 Jan;
92(4):668-677.
PMID: 29356269
Objectives: to compare the 1-year outcome between bioresorbable vascular scaffold (BVS), everolimus-eluting stent (EES), and drug-eluting balloon (DEB) for in-stent restenosis (ISR) treatment. Background: BVS has been proposed as alternative...